Global Liposome Drug Delivery Supply, Demand and Key Producers, 2026-2032
The global Liposome Drug Delivery market size is expected to reach $ 12300 million by 2032, rising at a market growth of 12.5% CAGR during the forecast period (2026-2032).
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
Global Liposome Drug Delivery key players include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. Global top five manufacturers hold a share about 60%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both with a share about 30 percent. In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer & Tumor Therapy, followed by Fungal Infection Therapy, etc.
This report studies the global Liposome Drug Delivery production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Liposome Drug Delivery and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Liposome Drug Delivery that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Liposome Drug Delivery total production and demand, 2021-2032, (K Vial)
Global Liposome Drug Delivery total production value, 2021-2032, (USD Million)
Global Liposome Drug Delivery production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Vial), (based on production site)
Global Liposome Drug Delivery consumption by region & country, CAGR, 2021-2032 & (K Vial)
U.S. VS China: Liposome Drug Delivery domestic production, consumption, key domestic manufacturers and share
Global Liposome Drug Delivery production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Vial)
Global Liposome Drug Delivery production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Vial)
Global Liposome Drug Delivery production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Vial)
This report profiles key players in the global Liposome Drug Delivery market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC, Teva Pharmaceutical, Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Liposome Drug Delivery market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Vial) and average price (USD/Vial) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Liposome Drug Delivery Market, By Region:
1. How big is the global Liposome Drug Delivery market?
2. What is the demand of the global Liposome Drug Delivery market?
3. What is the year over year growth of the global Liposome Drug Delivery market?
4. What is the production and production value of the global Liposome Drug Delivery market?
5. Who are the key producers in the global Liposome Drug Delivery market?
6. What are the growth factors driving the market demand?
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
Global Liposome Drug Delivery key players include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. Global top five manufacturers hold a share about 60%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both with a share about 30 percent. In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer & Tumor Therapy, followed by Fungal Infection Therapy, etc.
This report studies the global Liposome Drug Delivery production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Liposome Drug Delivery and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Liposome Drug Delivery that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Liposome Drug Delivery total production and demand, 2021-2032, (K Vial)
Global Liposome Drug Delivery total production value, 2021-2032, (USD Million)
Global Liposome Drug Delivery production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Vial), (based on production site)
Global Liposome Drug Delivery consumption by region & country, CAGR, 2021-2032 & (K Vial)
U.S. VS China: Liposome Drug Delivery domestic production, consumption, key domestic manufacturers and share
Global Liposome Drug Delivery production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Vial)
Global Liposome Drug Delivery production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Vial)
Global Liposome Drug Delivery production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Vial)
This report profiles key players in the global Liposome Drug Delivery market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC, Teva Pharmaceutical, Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Liposome Drug Delivery market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Vial) and average price (USD/Vial) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Liposome Drug Delivery Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Liposomal Doxorubicin
- Liposomal Amphoteracin B
- Liposomal Paclitaxel
- Others
- Fungal Infection Therapy
- Cancer & Tumor Therapy
- Others
- Gilead Sciences
- Pacira
- Sun Pharmaceutical
- Johnson & Johnson
- Luye Pharma
- Sigma-Tau
- Ipsen (Onivyde)
- CSPC
- Teva Pharmaceutical
- Novartis
- Fudan-Zhangjiang
1. How big is the global Liposome Drug Delivery market?
2. What is the demand of the global Liposome Drug Delivery market?
3. What is the year over year growth of the global Liposome Drug Delivery market?
4. What is the production and production value of the global Liposome Drug Delivery market?
5. Who are the key producers in the global Liposome Drug Delivery market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Liposome Drug Delivery Introduction
1.2 World Liposome Drug Delivery Supply & Forecast
1.2.1 World Liposome Drug Delivery Production Value (2021 & 2025 & 2032)
1.2.2 World Liposome Drug Delivery Production (2021-2032)
1.2.3 World Liposome Drug Delivery Pricing Trends (2021-2032)
1.3 World Liposome Drug Delivery Production by Region (Based on Production Site)
1.3.1 World Liposome Drug Delivery Production Value by Region (2021-2032)
1.3.2 World Liposome Drug Delivery Production by Region (2021-2032)
1.3.3 World Liposome Drug Delivery Average Price by Region (2021-2032)
1.3.4 North America Liposome Drug Delivery Production (2021-2032)
1.3.5 Europe Liposome Drug Delivery Production (2021-2032)
1.3.6 China Liposome Drug Delivery Production (2021-2032)
1.3.7 Japan Liposome Drug Delivery Production (2021-2032)
1.3.8 India Liposome Drug Delivery Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Liposome Drug Delivery Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Liposome Drug Delivery Major Market Trends
2 DEMAND SUMMARY
2.1 World Liposome Drug Delivery Demand (2021-2032)
2.2 World Liposome Drug Delivery Consumption by Region
2.2.1 World Liposome Drug Delivery Consumption by Region (2021-2026)
2.2.2 World Liposome Drug Delivery Consumption Forecast by Region (2027-2032)
2.3 United States Liposome Drug Delivery Consumption (2021-2032)
2.4 China Liposome Drug Delivery Consumption (2021-2032)
2.5 Europe Liposome Drug Delivery Consumption (2021-2032)
2.6 Japan Liposome Drug Delivery Consumption (2021-2032)
2.7 South Korea Liposome Drug Delivery Consumption (2021-2032)
2.8 ASEAN Liposome Drug Delivery Consumption (2021-2032)
2.9 India Liposome Drug Delivery Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Liposome Drug Delivery Production Value by Manufacturer (2021-2026)
3.2 World Liposome Drug Delivery Production by Manufacturer (2021-2026)
3.3 World Liposome Drug Delivery Average Price by Manufacturer (2021-2026)
3.4 Liposome Drug Delivery Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Liposome Drug Delivery Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Liposome Drug Delivery in 2025
3.5.3 Global Concentration Ratios (CR8) for Liposome Drug Delivery in 2025
3.6 Liposome Drug Delivery Market: Overall Company Footprint Analysis
3.6.1 Liposome Drug Delivery Market: Region Footprint
3.6.2 Liposome Drug Delivery Market: Company Product Type Footprint
3.6.3 Liposome Drug Delivery Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Liposome Drug Delivery Production Value Comparison
4.1.1 United States VS China: Liposome Drug Delivery Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Liposome Drug Delivery Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Liposome Drug Delivery Production Comparison
4.2.1 United States VS China: Liposome Drug Delivery Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Liposome Drug Delivery Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Liposome Drug Delivery Consumption Comparison
4.3.1 United States VS China: Liposome Drug Delivery Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Liposome Drug Delivery Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Liposome Drug Delivery Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Liposome Drug Delivery Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Liposome Drug Delivery Production Value (2021-2026)
4.4.3 United States Based Manufacturers Liposome Drug Delivery Production (2021-2026)
4.5 China Based Liposome Drug Delivery Manufacturers and Market Share
4.5.1 China Based Liposome Drug Delivery Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Liposome Drug Delivery Production Value (2021-2026)
4.5.3 China Based Manufacturers Liposome Drug Delivery Production (2021-2026)
4.6 Rest of World Based Liposome Drug Delivery Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Liposome Drug Delivery Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Liposome Drug Delivery Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Liposome Drug Delivery Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Liposome Drug Delivery Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Liposomal Doxorubicin
5.2.2 Liposomal Amphoteracin B
5.2.3 Liposomal Paclitaxel
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Liposome Drug Delivery Production by Type (2021-2032)
5.3.2 World Liposome Drug Delivery Production Value by Type (2021-2032)
5.3.3 World Liposome Drug Delivery Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Liposome Drug Delivery Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Fungal Infection Therapy
6.2.2 Cancer & Tumor Therapy
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Liposome Drug Delivery Production by Application (2021-2032)
6.3.2 World Liposome Drug Delivery Production Value by Application (2021-2032)
6.3.3 World Liposome Drug Delivery Average Price by Application (2021-2032)
7 COMPANY PROFILES
7.1 Gilead Sciences
7.1.1 Gilead Sciences Details
7.1.2 Gilead Sciences Major Business
7.1.3 Gilead Sciences Liposome Drug Delivery Product and Services
7.1.4 Gilead Sciences Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Gilead Sciences Recent Developments/Updates
7.1.6 Gilead Sciences Competitive Strengths & Weaknesses
7.2 Pacira
7.2.1 Pacira Details
7.2.2 Pacira Major Business
7.2.3 Pacira Liposome Drug Delivery Product and Services
7.2.4 Pacira Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.2.5 Pacira Recent Developments/Updates
7.2.6 Pacira Competitive Strengths & Weaknesses
7.3 Sun Pharmaceutical
7.3.1 Sun Pharmaceutical Details
7.3.2 Sun Pharmaceutical Major Business
7.3.3 Sun Pharmaceutical Liposome Drug Delivery Product and Services
7.3.4 Sun Pharmaceutical Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.3.5 Sun Pharmaceutical Recent Developments/Updates
7.3.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Details
7.4.2 Johnson & Johnson Major Business
7.4.3 Johnson & Johnson Liposome Drug Delivery Product and Services
7.4.4 Johnson & Johnson Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.4.5 Johnson & Johnson Recent Developments/Updates
7.4.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.5 Luye Pharma
7.5.1 Luye Pharma Details
7.5.2 Luye Pharma Major Business
7.5.3 Luye Pharma Liposome Drug Delivery Product and Services
7.5.4 Luye Pharma Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.5.5 Luye Pharma Recent Developments/Updates
7.5.6 Luye Pharma Competitive Strengths & Weaknesses
7.6 Sigma-Tau
7.6.1 Sigma-Tau Details
7.6.2 Sigma-Tau Major Business
7.6.3 Sigma-Tau Liposome Drug Delivery Product and Services
7.6.4 Sigma-Tau Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.6.5 Sigma-Tau Recent Developments/Updates
7.6.6 Sigma-Tau Competitive Strengths & Weaknesses
7.7 Ipsen (Onivyde)
7.7.1 Ipsen (Onivyde) Details
7.7.2 Ipsen (Onivyde) Major Business
7.7.3 Ipsen (Onivyde) Liposome Drug Delivery Product and Services
7.7.4 Ipsen (Onivyde) Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.7.5 Ipsen (Onivyde) Recent Developments/Updates
7.7.6 Ipsen (Onivyde) Competitive Strengths & Weaknesses
7.8 CSPC
7.8.1 CSPC Details
7.8.2 CSPC Major Business
7.8.3 CSPC Liposome Drug Delivery Product and Services
7.8.4 CSPC Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.8.5 CSPC Recent Developments/Updates
7.8.6 CSPC Competitive Strengths & Weaknesses
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Details
7.9.2 Teva Pharmaceutical Major Business
7.9.3 Teva Pharmaceutical Liposome Drug Delivery Product and Services
7.9.4 Teva Pharmaceutical Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.9.5 Teva Pharmaceutical Recent Developments/Updates
7.9.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
7.10 Novartis
7.10.1 Novartis Details
7.10.2 Novartis Major Business
7.10.3 Novartis Liposome Drug Delivery Product and Services
7.10.4 Novartis Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.10.5 Novartis Recent Developments/Updates
7.10.6 Novartis Competitive Strengths & Weaknesses
7.11 Fudan-Zhangjiang
7.11.1 Fudan-Zhangjiang Details
7.11.2 Fudan-Zhangjiang Major Business
7.11.3 Fudan-Zhangjiang Liposome Drug Delivery Product and Services
7.11.4 Fudan-Zhangjiang Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.11.5 Fudan-Zhangjiang Recent Developments/Updates
7.11.6 Fudan-Zhangjiang Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Liposome Drug Delivery Industry Chain
8.2 Liposome Drug Delivery Upstream Analysis
8.2.1 Liposome Drug Delivery Core Raw Materials
8.2.2 Main Manufacturers of Liposome Drug Delivery Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Liposome Drug Delivery Production Mode
8.6 Liposome Drug Delivery Procurement Model
8.7 Liposome Drug Delivery Industry Sales Model and Sales Channels
8.7.1 Liposome Drug Delivery Sales Model
8.7.2 Liposome Drug Delivery Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Liposome Drug Delivery Introduction
1.2 World Liposome Drug Delivery Supply & Forecast
1.2.1 World Liposome Drug Delivery Production Value (2021 & 2025 & 2032)
1.2.2 World Liposome Drug Delivery Production (2021-2032)
1.2.3 World Liposome Drug Delivery Pricing Trends (2021-2032)
1.3 World Liposome Drug Delivery Production by Region (Based on Production Site)
1.3.1 World Liposome Drug Delivery Production Value by Region (2021-2032)
1.3.2 World Liposome Drug Delivery Production by Region (2021-2032)
1.3.3 World Liposome Drug Delivery Average Price by Region (2021-2032)
1.3.4 North America Liposome Drug Delivery Production (2021-2032)
1.3.5 Europe Liposome Drug Delivery Production (2021-2032)
1.3.6 China Liposome Drug Delivery Production (2021-2032)
1.3.7 Japan Liposome Drug Delivery Production (2021-2032)
1.3.8 India Liposome Drug Delivery Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Liposome Drug Delivery Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Liposome Drug Delivery Major Market Trends
2 DEMAND SUMMARY
2.1 World Liposome Drug Delivery Demand (2021-2032)
2.2 World Liposome Drug Delivery Consumption by Region
2.2.1 World Liposome Drug Delivery Consumption by Region (2021-2026)
2.2.2 World Liposome Drug Delivery Consumption Forecast by Region (2027-2032)
2.3 United States Liposome Drug Delivery Consumption (2021-2032)
2.4 China Liposome Drug Delivery Consumption (2021-2032)
2.5 Europe Liposome Drug Delivery Consumption (2021-2032)
2.6 Japan Liposome Drug Delivery Consumption (2021-2032)
2.7 South Korea Liposome Drug Delivery Consumption (2021-2032)
2.8 ASEAN Liposome Drug Delivery Consumption (2021-2032)
2.9 India Liposome Drug Delivery Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Liposome Drug Delivery Production Value by Manufacturer (2021-2026)
3.2 World Liposome Drug Delivery Production by Manufacturer (2021-2026)
3.3 World Liposome Drug Delivery Average Price by Manufacturer (2021-2026)
3.4 Liposome Drug Delivery Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Liposome Drug Delivery Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Liposome Drug Delivery in 2025
3.5.3 Global Concentration Ratios (CR8) for Liposome Drug Delivery in 2025
3.6 Liposome Drug Delivery Market: Overall Company Footprint Analysis
3.6.1 Liposome Drug Delivery Market: Region Footprint
3.6.2 Liposome Drug Delivery Market: Company Product Type Footprint
3.6.3 Liposome Drug Delivery Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Liposome Drug Delivery Production Value Comparison
4.1.1 United States VS China: Liposome Drug Delivery Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Liposome Drug Delivery Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Liposome Drug Delivery Production Comparison
4.2.1 United States VS China: Liposome Drug Delivery Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Liposome Drug Delivery Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Liposome Drug Delivery Consumption Comparison
4.3.1 United States VS China: Liposome Drug Delivery Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Liposome Drug Delivery Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Liposome Drug Delivery Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Liposome Drug Delivery Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Liposome Drug Delivery Production Value (2021-2026)
4.4.3 United States Based Manufacturers Liposome Drug Delivery Production (2021-2026)
4.5 China Based Liposome Drug Delivery Manufacturers and Market Share
4.5.1 China Based Liposome Drug Delivery Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Liposome Drug Delivery Production Value (2021-2026)
4.5.3 China Based Manufacturers Liposome Drug Delivery Production (2021-2026)
4.6 Rest of World Based Liposome Drug Delivery Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Liposome Drug Delivery Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Liposome Drug Delivery Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Liposome Drug Delivery Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Liposome Drug Delivery Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Liposomal Doxorubicin
5.2.2 Liposomal Amphoteracin B
5.2.3 Liposomal Paclitaxel
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Liposome Drug Delivery Production by Type (2021-2032)
5.3.2 World Liposome Drug Delivery Production Value by Type (2021-2032)
5.3.3 World Liposome Drug Delivery Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Liposome Drug Delivery Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Fungal Infection Therapy
6.2.2 Cancer & Tumor Therapy
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Liposome Drug Delivery Production by Application (2021-2032)
6.3.2 World Liposome Drug Delivery Production Value by Application (2021-2032)
6.3.3 World Liposome Drug Delivery Average Price by Application (2021-2032)
7 COMPANY PROFILES
7.1 Gilead Sciences
7.1.1 Gilead Sciences Details
7.1.2 Gilead Sciences Major Business
7.1.3 Gilead Sciences Liposome Drug Delivery Product and Services
7.1.4 Gilead Sciences Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Gilead Sciences Recent Developments/Updates
7.1.6 Gilead Sciences Competitive Strengths & Weaknesses
7.2 Pacira
7.2.1 Pacira Details
7.2.2 Pacira Major Business
7.2.3 Pacira Liposome Drug Delivery Product and Services
7.2.4 Pacira Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.2.5 Pacira Recent Developments/Updates
7.2.6 Pacira Competitive Strengths & Weaknesses
7.3 Sun Pharmaceutical
7.3.1 Sun Pharmaceutical Details
7.3.2 Sun Pharmaceutical Major Business
7.3.3 Sun Pharmaceutical Liposome Drug Delivery Product and Services
7.3.4 Sun Pharmaceutical Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.3.5 Sun Pharmaceutical Recent Developments/Updates
7.3.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Details
7.4.2 Johnson & Johnson Major Business
7.4.3 Johnson & Johnson Liposome Drug Delivery Product and Services
7.4.4 Johnson & Johnson Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.4.5 Johnson & Johnson Recent Developments/Updates
7.4.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.5 Luye Pharma
7.5.1 Luye Pharma Details
7.5.2 Luye Pharma Major Business
7.5.3 Luye Pharma Liposome Drug Delivery Product and Services
7.5.4 Luye Pharma Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.5.5 Luye Pharma Recent Developments/Updates
7.5.6 Luye Pharma Competitive Strengths & Weaknesses
7.6 Sigma-Tau
7.6.1 Sigma-Tau Details
7.6.2 Sigma-Tau Major Business
7.6.3 Sigma-Tau Liposome Drug Delivery Product and Services
7.6.4 Sigma-Tau Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.6.5 Sigma-Tau Recent Developments/Updates
7.6.6 Sigma-Tau Competitive Strengths & Weaknesses
7.7 Ipsen (Onivyde)
7.7.1 Ipsen (Onivyde) Details
7.7.2 Ipsen (Onivyde) Major Business
7.7.3 Ipsen (Onivyde) Liposome Drug Delivery Product and Services
7.7.4 Ipsen (Onivyde) Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.7.5 Ipsen (Onivyde) Recent Developments/Updates
7.7.6 Ipsen (Onivyde) Competitive Strengths & Weaknesses
7.8 CSPC
7.8.1 CSPC Details
7.8.2 CSPC Major Business
7.8.3 CSPC Liposome Drug Delivery Product and Services
7.8.4 CSPC Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.8.5 CSPC Recent Developments/Updates
7.8.6 CSPC Competitive Strengths & Weaknesses
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Details
7.9.2 Teva Pharmaceutical Major Business
7.9.3 Teva Pharmaceutical Liposome Drug Delivery Product and Services
7.9.4 Teva Pharmaceutical Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.9.5 Teva Pharmaceutical Recent Developments/Updates
7.9.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
7.10 Novartis
7.10.1 Novartis Details
7.10.2 Novartis Major Business
7.10.3 Novartis Liposome Drug Delivery Product and Services
7.10.4 Novartis Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.10.5 Novartis Recent Developments/Updates
7.10.6 Novartis Competitive Strengths & Weaknesses
7.11 Fudan-Zhangjiang
7.11.1 Fudan-Zhangjiang Details
7.11.2 Fudan-Zhangjiang Major Business
7.11.3 Fudan-Zhangjiang Liposome Drug Delivery Product and Services
7.11.4 Fudan-Zhangjiang Liposome Drug Delivery Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.11.5 Fudan-Zhangjiang Recent Developments/Updates
7.11.6 Fudan-Zhangjiang Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Liposome Drug Delivery Industry Chain
8.2 Liposome Drug Delivery Upstream Analysis
8.2.1 Liposome Drug Delivery Core Raw Materials
8.2.2 Main Manufacturers of Liposome Drug Delivery Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Liposome Drug Delivery Production Mode
8.6 Liposome Drug Delivery Procurement Model
8.7 Liposome Drug Delivery Industry Sales Model and Sales Channels
8.7.1 Liposome Drug Delivery Sales Model
8.7.2 Liposome Drug Delivery Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Liposome Drug Delivery Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Liposome Drug Delivery Production Value by Region (2021-2026) & (USD Million)
Table 3. World Liposome Drug Delivery Production Value by Region (2027-2032) & (USD Million)
Table 4. World Liposome Drug Delivery Production Value Market Share by Region (2021-2026)
Table 5. World Liposome Drug Delivery Production Value Market Share by Region (2027-2032)
Table 6. World Liposome Drug Delivery Production by Region (2021-2026) & (K Vial)
Table 7. World Liposome Drug Delivery Production by Region (2027-2032) & (K Vial)
Table 8. World Liposome Drug Delivery Production Market Share by Region (2021-2026)
Table 9. World Liposome Drug Delivery Production Market Share by Region (2027-2032)
Table 10. World Liposome Drug Delivery Average Price by Region (2021-2026) & (USD/Vial)
Table 11. World Liposome Drug Delivery Average Price by Region (2027-2032) & (USD/Vial)
Table 12. Liposome Drug Delivery Major Market Trends
Table 13. World Liposome Drug Delivery Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Vial)
Table 14. World Liposome Drug Delivery Consumption by Region (2021-2026) & (K Vial)
Table 15. World Liposome Drug Delivery Consumption Forecast by Region (2027-2032) & (K Vial)
Table 16. World Liposome Drug Delivery Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Liposome Drug Delivery Producers in 2025
Table 18. World Liposome Drug Delivery Production by Manufacturer (2021-2026) & (K Vial)
Table 19. Production Market Share of Key Liposome Drug Delivery Producers in 2025
Table 20. World Liposome Drug Delivery Average Price by Manufacturer (2021-2026) & (USD/Vial)
Table 21. Global Liposome Drug Delivery Company Evaluation Quadrant
Table 22. World Liposome Drug Delivery Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Liposome Drug Delivery Production Site of Key Manufacturer
Table 24. Liposome Drug Delivery Market: Company Product Type Footprint
Table 25. Liposome Drug Delivery Market: Company Product Application Footprint
Table 26. Liposome Drug Delivery Competitive Factors
Table 27. Liposome Drug Delivery New Entrant and Capacity Expansion Plans
Table 28. Liposome Drug Delivery Mergers & Acquisitions Activity
Table 29. United States VS China Liposome Drug Delivery Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Liposome Drug Delivery Production Comparison, (2021 & 2025 & 2032) & (K Vial)
Table 31. United States VS China Liposome Drug Delivery Consumption Comparison, (2021 & 2025 & 2032) & (K Vial)
Table 32. United States Based Liposome Drug Delivery Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Liposome Drug Delivery Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Liposome Drug Delivery Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Liposome Drug Delivery Production (2021-2026) & (K Vial)
Table 36. United States Based Manufacturers Liposome Drug Delivery Production Market Share (2021-2026)
Table 37. China Based Liposome Drug Delivery Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Liposome Drug Delivery Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Liposome Drug Delivery Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Liposome Drug Delivery Production, (2021-2026) & (K Vial)
Table 41. China Based Manufacturers Liposome Drug Delivery Production Market Share (2021-2026)
Table 42. Rest of World Based Liposome Drug Delivery Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Liposome Drug Delivery Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Liposome Drug Delivery Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Liposome Drug Delivery Production, (2021-2026) & (K Vial)
Table 46. Rest of World Based Manufacturers Liposome Drug Delivery Production Market Share (2021-2026)
Table 47. World Liposome Drug Delivery Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Liposome Drug Delivery Production by Type (2021-2026) & (K Vial)
Table 49. World Liposome Drug Delivery Production by Type (2027-2032) & (K Vial)
Table 50. World Liposome Drug Delivery Production Value by Type (2021-2026) & (USD Million)
Table 51. World Liposome Drug Delivery Production Value by Type (2027-2032) & (USD Million)
Table 52. World Liposome Drug Delivery Average Price by Type (2021-2026) & (USD/Vial)
Table 53. World Liposome Drug Delivery Average Price by Type (2027-2032) & (USD/Vial)
Table 54. World Liposome Drug Delivery Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Liposome Drug Delivery Production by Application (2021-2026) & (K Vial)
Table 56. World Liposome Drug Delivery Production by Application (2027-2032) & (K Vial)
Table 57. World Liposome Drug Delivery Production Value by Application (2021-2026) & (USD Million)
Table 58. World Liposome Drug Delivery Production Value by Application (2027-2032) & (USD Million)
Table 59. World Liposome Drug Delivery Average Price by Application (2021-2026) & (USD/Vial)
Table 60. World Liposome Drug Delivery Average Price by Application (2027-2032) & (USD/Vial)
Table 61. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 62. Gilead Sciences Major Business
Table 63. Gilead Sciences Liposome Drug Delivery Product and Services
Table 64. Gilead Sciences Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Gilead Sciences Recent Developments/Updates
Table 66. Gilead Sciences Competitive Strengths & Weaknesses
Table 67. Pacira Basic Information, Manufacturing Base and Competitors
Table 68. Pacira Major Business
Table 69. Pacira Liposome Drug Delivery Product and Services
Table 70. Pacira Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Pacira Recent Developments/Updates
Table 72. Pacira Competitive Strengths & Weaknesses
Table 73. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Sun Pharmaceutical Major Business
Table 75. Sun Pharmaceutical Liposome Drug Delivery Product and Services
Table 76. Sun Pharmaceutical Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Sun Pharmaceutical Recent Developments/Updates
Table 78. Sun Pharmaceutical Competitive Strengths & Weaknesses
Table 79. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 80. Johnson & Johnson Major Business
Table 81. Johnson & Johnson Liposome Drug Delivery Product and Services
Table 82. Johnson & Johnson Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Johnson & Johnson Recent Developments/Updates
Table 84. Johnson & Johnson Competitive Strengths & Weaknesses
Table 85. Luye Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Luye Pharma Major Business
Table 87. Luye Pharma Liposome Drug Delivery Product and Services
Table 88. Luye Pharma Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Luye Pharma Recent Developments/Updates
Table 90. Luye Pharma Competitive Strengths & Weaknesses
Table 91. Sigma-Tau Basic Information, Manufacturing Base and Competitors
Table 92. Sigma-Tau Major Business
Table 93. Sigma-Tau Liposome Drug Delivery Product and Services
Table 94. Sigma-Tau Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Sigma-Tau Recent Developments/Updates
Table 96. Sigma-Tau Competitive Strengths & Weaknesses
Table 97. Ipsen (Onivyde) Basic Information, Manufacturing Base and Competitors
Table 98. Ipsen (Onivyde) Major Business
Table 99. Ipsen (Onivyde) Liposome Drug Delivery Product and Services
Table 100. Ipsen (Onivyde) Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Ipsen (Onivyde) Recent Developments/Updates
Table 102. Ipsen (Onivyde) Competitive Strengths & Weaknesses
Table 103. CSPC Basic Information, Manufacturing Base and Competitors
Table 104. CSPC Major Business
Table 105. CSPC Liposome Drug Delivery Product and Services
Table 106. CSPC Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. CSPC Recent Developments/Updates
Table 108. CSPC Competitive Strengths & Weaknesses
Table 109. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. Teva Pharmaceutical Major Business
Table 111. Teva Pharmaceutical Liposome Drug Delivery Product and Services
Table 112. Teva Pharmaceutical Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Teva Pharmaceutical Recent Developments/Updates
Table 114. Teva Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Novartis Basic Information, Manufacturing Base and Competitors
Table 116. Novartis Major Business
Table 117. Novartis Liposome Drug Delivery Product and Services
Table 118. Novartis Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Novartis Recent Developments/Updates
Table 120. Novartis Competitive Strengths & Weaknesses
Table 121. Fudan-Zhangjiang Basic Information, Manufacturing Base and Competitors
Table 122. Fudan-Zhangjiang Major Business
Table 123. Fudan-Zhangjiang Liposome Drug Delivery Product and Services
Table 124. Fudan-Zhangjiang Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Fudan-Zhangjiang Recent Developments/Updates
Table 126. Fudan-Zhangjiang Competitive Strengths & Weaknesses
Table 127. Global Key Players of Liposome Drug Delivery Upstream (Raw Materials)
Table 128. Global Liposome Drug Delivery Typical Customers
Table 129. Liposome Drug Delivery Typical Distributors
Table 1. World Liposome Drug Delivery Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Liposome Drug Delivery Production Value by Region (2021-2026) & (USD Million)
Table 3. World Liposome Drug Delivery Production Value by Region (2027-2032) & (USD Million)
Table 4. World Liposome Drug Delivery Production Value Market Share by Region (2021-2026)
Table 5. World Liposome Drug Delivery Production Value Market Share by Region (2027-2032)
Table 6. World Liposome Drug Delivery Production by Region (2021-2026) & (K Vial)
Table 7. World Liposome Drug Delivery Production by Region (2027-2032) & (K Vial)
Table 8. World Liposome Drug Delivery Production Market Share by Region (2021-2026)
Table 9. World Liposome Drug Delivery Production Market Share by Region (2027-2032)
Table 10. World Liposome Drug Delivery Average Price by Region (2021-2026) & (USD/Vial)
Table 11. World Liposome Drug Delivery Average Price by Region (2027-2032) & (USD/Vial)
Table 12. Liposome Drug Delivery Major Market Trends
Table 13. World Liposome Drug Delivery Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Vial)
Table 14. World Liposome Drug Delivery Consumption by Region (2021-2026) & (K Vial)
Table 15. World Liposome Drug Delivery Consumption Forecast by Region (2027-2032) & (K Vial)
Table 16. World Liposome Drug Delivery Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Liposome Drug Delivery Producers in 2025
Table 18. World Liposome Drug Delivery Production by Manufacturer (2021-2026) & (K Vial)
Table 19. Production Market Share of Key Liposome Drug Delivery Producers in 2025
Table 20. World Liposome Drug Delivery Average Price by Manufacturer (2021-2026) & (USD/Vial)
Table 21. Global Liposome Drug Delivery Company Evaluation Quadrant
Table 22. World Liposome Drug Delivery Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Liposome Drug Delivery Production Site of Key Manufacturer
Table 24. Liposome Drug Delivery Market: Company Product Type Footprint
Table 25. Liposome Drug Delivery Market: Company Product Application Footprint
Table 26. Liposome Drug Delivery Competitive Factors
Table 27. Liposome Drug Delivery New Entrant and Capacity Expansion Plans
Table 28. Liposome Drug Delivery Mergers & Acquisitions Activity
Table 29. United States VS China Liposome Drug Delivery Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Liposome Drug Delivery Production Comparison, (2021 & 2025 & 2032) & (K Vial)
Table 31. United States VS China Liposome Drug Delivery Consumption Comparison, (2021 & 2025 & 2032) & (K Vial)
Table 32. United States Based Liposome Drug Delivery Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Liposome Drug Delivery Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Liposome Drug Delivery Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Liposome Drug Delivery Production (2021-2026) & (K Vial)
Table 36. United States Based Manufacturers Liposome Drug Delivery Production Market Share (2021-2026)
Table 37. China Based Liposome Drug Delivery Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Liposome Drug Delivery Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Liposome Drug Delivery Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Liposome Drug Delivery Production, (2021-2026) & (K Vial)
Table 41. China Based Manufacturers Liposome Drug Delivery Production Market Share (2021-2026)
Table 42. Rest of World Based Liposome Drug Delivery Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Liposome Drug Delivery Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Liposome Drug Delivery Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Liposome Drug Delivery Production, (2021-2026) & (K Vial)
Table 46. Rest of World Based Manufacturers Liposome Drug Delivery Production Market Share (2021-2026)
Table 47. World Liposome Drug Delivery Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Liposome Drug Delivery Production by Type (2021-2026) & (K Vial)
Table 49. World Liposome Drug Delivery Production by Type (2027-2032) & (K Vial)
Table 50. World Liposome Drug Delivery Production Value by Type (2021-2026) & (USD Million)
Table 51. World Liposome Drug Delivery Production Value by Type (2027-2032) & (USD Million)
Table 52. World Liposome Drug Delivery Average Price by Type (2021-2026) & (USD/Vial)
Table 53. World Liposome Drug Delivery Average Price by Type (2027-2032) & (USD/Vial)
Table 54. World Liposome Drug Delivery Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Liposome Drug Delivery Production by Application (2021-2026) & (K Vial)
Table 56. World Liposome Drug Delivery Production by Application (2027-2032) & (K Vial)
Table 57. World Liposome Drug Delivery Production Value by Application (2021-2026) & (USD Million)
Table 58. World Liposome Drug Delivery Production Value by Application (2027-2032) & (USD Million)
Table 59. World Liposome Drug Delivery Average Price by Application (2021-2026) & (USD/Vial)
Table 60. World Liposome Drug Delivery Average Price by Application (2027-2032) & (USD/Vial)
Table 61. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 62. Gilead Sciences Major Business
Table 63. Gilead Sciences Liposome Drug Delivery Product and Services
Table 64. Gilead Sciences Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Gilead Sciences Recent Developments/Updates
Table 66. Gilead Sciences Competitive Strengths & Weaknesses
Table 67. Pacira Basic Information, Manufacturing Base and Competitors
Table 68. Pacira Major Business
Table 69. Pacira Liposome Drug Delivery Product and Services
Table 70. Pacira Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Pacira Recent Developments/Updates
Table 72. Pacira Competitive Strengths & Weaknesses
Table 73. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Sun Pharmaceutical Major Business
Table 75. Sun Pharmaceutical Liposome Drug Delivery Product and Services
Table 76. Sun Pharmaceutical Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Sun Pharmaceutical Recent Developments/Updates
Table 78. Sun Pharmaceutical Competitive Strengths & Weaknesses
Table 79. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 80. Johnson & Johnson Major Business
Table 81. Johnson & Johnson Liposome Drug Delivery Product and Services
Table 82. Johnson & Johnson Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Johnson & Johnson Recent Developments/Updates
Table 84. Johnson & Johnson Competitive Strengths & Weaknesses
Table 85. Luye Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Luye Pharma Major Business
Table 87. Luye Pharma Liposome Drug Delivery Product and Services
Table 88. Luye Pharma Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Luye Pharma Recent Developments/Updates
Table 90. Luye Pharma Competitive Strengths & Weaknesses
Table 91. Sigma-Tau Basic Information, Manufacturing Base and Competitors
Table 92. Sigma-Tau Major Business
Table 93. Sigma-Tau Liposome Drug Delivery Product and Services
Table 94. Sigma-Tau Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Sigma-Tau Recent Developments/Updates
Table 96. Sigma-Tau Competitive Strengths & Weaknesses
Table 97. Ipsen (Onivyde) Basic Information, Manufacturing Base and Competitors
Table 98. Ipsen (Onivyde) Major Business
Table 99. Ipsen (Onivyde) Liposome Drug Delivery Product and Services
Table 100. Ipsen (Onivyde) Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Ipsen (Onivyde) Recent Developments/Updates
Table 102. Ipsen (Onivyde) Competitive Strengths & Weaknesses
Table 103. CSPC Basic Information, Manufacturing Base and Competitors
Table 104. CSPC Major Business
Table 105. CSPC Liposome Drug Delivery Product and Services
Table 106. CSPC Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. CSPC Recent Developments/Updates
Table 108. CSPC Competitive Strengths & Weaknesses
Table 109. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. Teva Pharmaceutical Major Business
Table 111. Teva Pharmaceutical Liposome Drug Delivery Product and Services
Table 112. Teva Pharmaceutical Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Teva Pharmaceutical Recent Developments/Updates
Table 114. Teva Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Novartis Basic Information, Manufacturing Base and Competitors
Table 116. Novartis Major Business
Table 117. Novartis Liposome Drug Delivery Product and Services
Table 118. Novartis Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Novartis Recent Developments/Updates
Table 120. Novartis Competitive Strengths & Weaknesses
Table 121. Fudan-Zhangjiang Basic Information, Manufacturing Base and Competitors
Table 122. Fudan-Zhangjiang Major Business
Table 123. Fudan-Zhangjiang Liposome Drug Delivery Product and Services
Table 124. Fudan-Zhangjiang Liposome Drug Delivery Production (K Vial), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Fudan-Zhangjiang Recent Developments/Updates
Table 126. Fudan-Zhangjiang Competitive Strengths & Weaknesses
Table 127. Global Key Players of Liposome Drug Delivery Upstream (Raw Materials)
Table 128. Global Liposome Drug Delivery Typical Customers
Table 129. Liposome Drug Delivery Typical Distributors
LIST OF FIGURES
Figure 1. Liposome Drug Delivery Picture
Figure 2. World Liposome Drug Delivery Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Liposome Drug Delivery Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Liposome Drug Delivery Production (2021-2032) & (K Vial)
Figure 5. World Liposome Drug Delivery Average Price (2021-2032) & (USD/Vial)
Figure 6. World Liposome Drug Delivery Production Value Market Share by Region (2021-2032)
Figure 7. World Liposome Drug Delivery Production Market Share by Region (2021-2032)
Figure 8. North America Liposome Drug Delivery Production (2021-2032) & (K Vial)
Figure 9. Europe Liposome Drug Delivery Production (2021-2032) & (K Vial)
Figure 10. China Liposome Drug Delivery Production (2021-2032) & (K Vial)
Figure 11. Japan Liposome Drug Delivery Production (2021-2032) & (K Vial)
Figure 12. India Liposome Drug Delivery Production (2021-2032) & (K Vial)
Figure 13. Liposome Drug Delivery Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Liposome Drug Delivery Consumption (2021-2032) & (K Vial)
Figure 16. World Liposome Drug Delivery Consumption Market Share by Region (2021-2032)
Figure 17. United States Liposome Drug Delivery Consumption (2021-2032) & (K Vial)
Figure 18. China Liposome Drug Delivery Consumption (2021-2032) & (K Vial)
Figure 19. Europe Liposome Drug Delivery Consumption (2021-2032) & (K Vial)
Figure 20. Japan Liposome Drug Delivery Consumption (2021-2032) & (K Vial)
Figure 21. South Korea Liposome Drug Delivery Consumption (2021-2032) & (K Vial)
Figure 22. ASEAN Liposome Drug Delivery Consumption (2021-2032) & (K Vial)
Figure 23. India Liposome Drug Delivery Consumption (2021-2032) & (K Vial)
Figure 24. Producer Shipments of Liposome Drug Delivery by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Liposome Drug Delivery Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Liposome Drug Delivery Markets in 2025
Figure 27. United States VS China: Liposome Drug Delivery Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Liposome Drug Delivery Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Liposome Drug Delivery Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Liposome Drug Delivery Production Market Share 2025
Figure 31. China Based Manufacturers Liposome Drug Delivery Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Liposome Drug Delivery Production Market Share 2025
Figure 33. World Liposome Drug Delivery Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Liposome Drug Delivery Production Value Market Share by Type in 2025
Figure 35. Liposomal Doxorubicin
Figure 36. Liposomal Amphoteracin B
Figure 37. Liposomal Paclitaxel
Figure 38. Others
Figure 39. World Liposome Drug Delivery Production Market Share by Type (2021-2032)
Figure 40. World Liposome Drug Delivery Production Value Market Share by Type (2021-2032)
Figure 41. World Liposome Drug Delivery Average Price by Type (2021-2032) & (USD/Vial)
Figure 42. World Liposome Drug Delivery Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 43. World Liposome Drug Delivery Production Value Market Share by Application in 2025
Figure 44. Fungal Infection Therapy
Figure 45. Cancer & Tumor Therapy
Figure 46. Others
Figure 47. World Liposome Drug Delivery Production Market Share by Application (2021-2032)
Figure 48. World Liposome Drug Delivery Production Value Market Share by Application (2021-2032)
Figure 49. World Liposome Drug Delivery Average Price by Application (2021-2032) & (USD/Vial)
Figure 50. Liposome Drug Delivery Industry Chain
Figure 51. Liposome Drug Delivery Procurement Model
Figure 52. Liposome Drug Delivery Sales Model
Figure 53. Liposome Drug Delivery Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Liposome Drug Delivery Picture
Figure 2. World Liposome Drug Delivery Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Liposome Drug Delivery Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Liposome Drug Delivery Production (2021-2032) & (K Vial)
Figure 5. World Liposome Drug Delivery Average Price (2021-2032) & (USD/Vial)
Figure 6. World Liposome Drug Delivery Production Value Market Share by Region (2021-2032)
Figure 7. World Liposome Drug Delivery Production Market Share by Region (2021-2032)
Figure 8. North America Liposome Drug Delivery Production (2021-2032) & (K Vial)
Figure 9. Europe Liposome Drug Delivery Production (2021-2032) & (K Vial)
Figure 10. China Liposome Drug Delivery Production (2021-2032) & (K Vial)
Figure 11. Japan Liposome Drug Delivery Production (2021-2032) & (K Vial)
Figure 12. India Liposome Drug Delivery Production (2021-2032) & (K Vial)
Figure 13. Liposome Drug Delivery Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Liposome Drug Delivery Consumption (2021-2032) & (K Vial)
Figure 16. World Liposome Drug Delivery Consumption Market Share by Region (2021-2032)
Figure 17. United States Liposome Drug Delivery Consumption (2021-2032) & (K Vial)
Figure 18. China Liposome Drug Delivery Consumption (2021-2032) & (K Vial)
Figure 19. Europe Liposome Drug Delivery Consumption (2021-2032) & (K Vial)
Figure 20. Japan Liposome Drug Delivery Consumption (2021-2032) & (K Vial)
Figure 21. South Korea Liposome Drug Delivery Consumption (2021-2032) & (K Vial)
Figure 22. ASEAN Liposome Drug Delivery Consumption (2021-2032) & (K Vial)
Figure 23. India Liposome Drug Delivery Consumption (2021-2032) & (K Vial)
Figure 24. Producer Shipments of Liposome Drug Delivery by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Liposome Drug Delivery Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Liposome Drug Delivery Markets in 2025
Figure 27. United States VS China: Liposome Drug Delivery Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Liposome Drug Delivery Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Liposome Drug Delivery Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Liposome Drug Delivery Production Market Share 2025
Figure 31. China Based Manufacturers Liposome Drug Delivery Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Liposome Drug Delivery Production Market Share 2025
Figure 33. World Liposome Drug Delivery Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Liposome Drug Delivery Production Value Market Share by Type in 2025
Figure 35. Liposomal Doxorubicin
Figure 36. Liposomal Amphoteracin B
Figure 37. Liposomal Paclitaxel
Figure 38. Others
Figure 39. World Liposome Drug Delivery Production Market Share by Type (2021-2032)
Figure 40. World Liposome Drug Delivery Production Value Market Share by Type (2021-2032)
Figure 41. World Liposome Drug Delivery Average Price by Type (2021-2032) & (USD/Vial)
Figure 42. World Liposome Drug Delivery Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 43. World Liposome Drug Delivery Production Value Market Share by Application in 2025
Figure 44. Fungal Infection Therapy
Figure 45. Cancer & Tumor Therapy
Figure 46. Others
Figure 47. World Liposome Drug Delivery Production Market Share by Application (2021-2032)
Figure 48. World Liposome Drug Delivery Production Value Market Share by Application (2021-2032)
Figure 49. World Liposome Drug Delivery Average Price by Application (2021-2032) & (USD/Vial)
Figure 50. Liposome Drug Delivery Industry Chain
Figure 51. Liposome Drug Delivery Procurement Model
Figure 52. Liposome Drug Delivery Sales Model
Figure 53. Liposome Drug Delivery Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
